← Back to Search

Scenario #1 for Artificial Intelligence

N/A
Recruiting
Led By Corey A Lester, PharmD, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day - single study visit
Awards & highlights

Study Summary

This trial is looking at whether using machine intelligence can help pharmacists work more efficiently and accurately by providing them with advice at different times during their tasks.

Who is the study for?
This trial is for licensed pharmacists in the U.S. who are at least 18 years old. They must have a PC or Mac with Windows 10 or MacOS, and an updated web browser like Chrome, Edge, Opera, Safari, or Firefox. A screen resolution of 1024x968 pixels and a webcam for eye tracking are also necessary.Check my eligibility
What is being tested?
The study tests how machine intelligence (MI) advice timing affects task time, accuracy, and trust in MI when pharmacists check for medication dispensing errors. It compares scenarios with no MI help against those where MI assists to prevent errors.See study design

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day - single study visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day - single study visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decision accuracy
Reaction time
Trust
+1 more
Secondary outcome measures
Cognitive effort
Usability
Workload

Trial Design

3Treatment groups
Experimental Treatment
Group I: Scenario #2Experimental Treatment3 Interventions
MI help will be displayed concurrently with the filled and reference images.
Group II: Scenario #1Experimental Treatment3 Interventions
MI help will be presented in the form of a pop-up message the participant's decision differs from the MI's determination.
Group III: No MI HelpExperimental Treatment3 Interventions
No MI help will be presented during the verification tasks

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,800 Previous Clinical Trials
6,379,104 Total Patients Enrolled
Corey A Lester, PharmD, PhDPrincipal InvestigatorUniversity of Michigan

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment phase for this investigation currently ongoing?

"As per clinicaltrials.gov, this study is actively seeking participants. It was initially posted on 4/11/2024 and last modified on 4/15/2024."

Answered by AI

What is the total number of participants being recruited for this research investigation?

"Indeed, information found on clinicaltrials.gov indicates that recruitment is ongoing for this particular study. The trial was initially listed on April 11th, 2024 and last modified on April 15th, 2024. This research endeavor aims to enroll a total of 36 participants from one designated site."

Answered by AI
~24 spots leftby Dec 2024